Trials / Completed
CompletedNCT01517932
Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia
Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia in Patients Undergoing Thoracotomy During Anesthesia Recovery Period
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Fang Luo · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Dexmedetomidine is a highly selective α2 adrenoreceptor agonist approved by the US FDA for short-term postoperative sedation and analgesia.It can also reduce the stress response without respiratory depression. In this prospective, randomized, double-blind, placebo-controlled study,we gave dexmedetomidine or saline placebo 1h before operations were over and assessed the effects of dexmedetomidine on stress response and postoperative analgesia in patients undergoing thoracotomy during anesthesia recovery period.
Detailed description
Dexmedetomidine can significantly reduce the emergence agitation and postoperative pain in patients who received chest surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexmedetomidine | In this arm,midazolam(0.03-0.05mg/kg), propofol(1.5-2.5mg/kg),sufentanil(0.6-0.82μg/kg )and rocuronium(0.8-1.0mg/kg) were used in anesthesia induction. Anaesthesia was maintained with propofol(4-6mg kg-1h-1),remifentanil (0.1-0.2 μg kg-1 min-1)and sevoflurane(1%).Propofol was titrated to maintain intraoperative Narcotrend values between 20 and 46. Patients in this arm received dexmedetomidine 0.2μg/kg i.v. during 10 minutes 1 hour before the end of surgery |
| DRUG | saline placebo | In this arm,midazolam(0.03-0.05mg/kg), propofol(1.5-2.5mg/kg),sufentanil(0.6-0.82μg/kg )and rocuronium(0.8-1.0mg/kg) were used in anesthesia induction. Anaesthesia was maintained with propofol(4-6mg kg-1h-1),remifentanil (0.1-0.2 μg kg-1 min-1)and sevoflurane(1%).Propofol was titrated to maintain intraoperative Narcotrend values between 20 and 46. Patients in this arm received saline placebo of the same volume i.v. during 10 minutes 1 hour before the end of surgery |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2012-01-25
- Last updated
- 2013-03-20
Source: ClinicalTrials.gov record NCT01517932. Inclusion in this directory is not an endorsement.